DP
CL icon

Dearborn Partners’s Colgate-Palmolive CL Stock Holding History

Dearborn Partners’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$375K Sell
4,395
-1,380
-24% -$123K 0.02% 204
2025
Q4 		$456K Buy
5,775
+30
+0.5% +$2.35K 0.02% 190
2025
Q3 		$459K Sell
5,745
-939
-14% -$80.1K 0.02% 183
2025
Q2 		$608K Buy
6,684
+931
+16% +$85K 0.03% 158
2025
Q1 		$539K Sell
5,753
-1,653
-22% -$148K 0.03% 161
2024
Q4 		$673K Buy
7,406
+433
+6% +$41.3K 0.03% 142
2024
Q3 		$724K Sell
6,973
-115
-2% -$11.7K 0.03% 136
2024
Q2 		$688K Sell
7,088
-241
-3% -$22.2K 0.03% 138
2024
Q1 		$660K Buy
7,329
+323
+5% +$27.4K 0.03% 145
2023
Q4 		$558K Buy
7,006
+239
+4% +$18K 0.02% 155
2023
Q3 		$481K Sell
6,767
-299
-4% -$22.4K 0.02% 158
2023
Q2 		$544K Sell
7,066
-1,691
-19% -$131K 0.02% 148
2023
Q1 		$658K Sell
8,757
-1,680
-16% -$125K 0.03% 131
2022
Q4 		$822K Sell
10,437
-1,018
-9% -$76.3K 0.03% 125
2022
Q3 		$805K Buy
11,455
+77
+0.7% +$6.04K 0.04% 125
2022
Q2 		$912K Buy
11,378
+586
+5% +$45.8K 0.04% 119
2022
Q1 		$818K Sell
10,792
-344
-3% -$27.2K 0.03% 135
2021
Q4 		$950K Buy
11,136
+383
+4% +$29.9K 0.03% 123
2021
Q3 		$813K Buy
10,753
+527
+5% +$41.8K 0.03% 127
2021
Q2 		$832K Buy
10,226
+778
+8% +$63.6K 0.03% 125
2021
Q1 		$745K Sell
9,448
-1,311
-12% -$103K 0.03% 126
2020
Q4 		$920K Buy
10,759
+1,878
+21% +$155K 0.04% 115
2020
Q3 		$685K Buy
8,881
+41
+0.5% +$3.13K 0.03% 118
2020
Q2 		$648K Buy
8,840
+473
+6% +$33.6K 0.04% 118
2020
Q1 		$555K Sell
8,367
-5,129
-38% -$362K 0.03% 119
2019
Q4 		$929K Buy
13,496
+3,858
+40% +$263K 0.05% 104
2019
Q3 		$708K Sell
9,638
-691
-7% -$50.1K 0.04% 106
2019
Q2 		$740K Buy
10,329
+1,007
+11% +$71.5K 0.05% 103
2019
Q1 		$639K Sell
9,322
-6,424
-41% -$415K 0.04% 105
2018
Q4 		$937K Buy
15,746
+701
+5% +$43.9K 0.07% 91
2018
Q3 		$1.01M Buy
15,045
+3,349
+29% +$223K 0.07% 88
2018
Q2 		$758K Buy
11,696
+266
+2% +$17.4K 0.06% 93
2018
Q1 		$819K Sell
11,430
-880
-7% -$63.3K 0.06% 86
2017
Q4 		$929K Sell
12,310
-682
-5% -$49.8K 0.07% 82
2017
Q3 		$946K Hold
12,992
– – 0.07% 82
2017
Q2 		$963K Sell
12,992
-100
-0.8% -$7.42K 0.07% 89
2017
Q1 		$958K Sell
13,092
-300
-2% -$21K 0.07% 92
2016
Q4 		$876K Sell
13,392
-1,780
-12% -$122K 0.07% 89
2016
Q3 		$1.13M Hold
15,172
– – 0.09% 92
2016
Q2 		$1.11M Sell
15,172
-1,200
-7% -$85.4K 0.1% 92
2016
Q1 		$1.16M Sell
16,372
-168
-1% -$11.2K 0.11% 94
2015
Q4 		$1.1M Sell
16,540
-300
-2% -$20K 0.1% 121
2015
Q3 		$1.07M Sell
16,840
-350
-2% -$22.9K 0.11% 127
2015
Q2 		$1.13M Sell
17,190
-2,991
-15% -$203K 0.11% 127
2015
Q1 		$1.4M Sell
20,181
-977
-5% -$67.5K 0.12% 141
2014
Q4 		$1.46M Sell
21,158
-1,192
-5% -$80.5K 0.13% 145
2014
Q3 		$1.46M Sell
22,350
-92
-0.4% -$6.07K 0.14% 146
2014
Q2 		$1.53M Buy
22,442
+6
+0% +$402 0.15% 136
2014
Q1 		$1.46M Sell
22,436
-1,384
-6% -$87.2K 0.16% 137
2013
Q4 		$1.55M Sell
23,820
-1,729
-7% -$111K 0.18% 128
2013
Q3 		$1.51M Sell
25,549
-402
-2% -$23.8K 0.2% 122
2013
Q2 		$1.49M Buy
+25,951
New +$1.54M 0.21% 127

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dearborn Partners's CL Position: Q1 2026 in Review

Dearborn Partners reduced its Colgate-Palmolive (CL) stake by 24% in Q1 2026, selling an estimated $123K and leaving 4,395 shares worth $375K. The position accounts for 0.02% of the portfolio, ranked #204.

Dearborn Partners first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.55M in Q4 2013. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Dearborn Partners held 4,395 shares of Colgate-Palmolive worth $375K as of Q1 2026.
  • Dearborn Partners sold 1,380 Colgate-Palmolive shares in Q1 2026, an estimated $123K.
  • Colgate-Palmolive made up 0.02% of Dearborn Partners's portfolio in Q1 2026, its #204 holding.
  • Dearborn Partners first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Dearborn Partners's Colgate-Palmolive position peaked at $1.55M in Q4 2013.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Dearborn Partners's 13F filing for Q1 2026, filed 12 May 2026.